🔎 Trials Near Me

Domov › Obézita › Florida › Orlando

Klinické štúdie Obézita v meste Orlando, FL

31 štúdií pre Obézita hľadá účastníkov v zariadeniach v meste Orlando a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Prebieha náborFáza 2
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Prebieha nábor
  • Orlando Health, Inc., Orlando
Vek 21 až 65 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
  • Kailera Clinical Site, Orlando
Vek 18 až 85 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07793929

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Prebieha náborFáza 2
  • Florida Institute For Clinical Research, LLC, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 míľ odtiaľ
  • Omega Research Orlando, Altamonte Springs · 9 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Prebieha náborFáza 3
  • Florida Institute for Clinical Research, LLC, Orlando
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Prebieha náborFáza 2
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 míľ odtiaľ
  • K2 Medical Research Maitland LLC, Main Office, Maitland · 6 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Prebieha náborFáza 2
  • Clinical Neuroscience Solutions, Orlando
Vek 18 až 75 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Prebieha náborFáza 3
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Prebieha náborFáza 3
  • Florida Inst For Clin Res LLC, Orlando
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Prebieha náborFáza 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Prebieha náborFáza 3
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
Vek 6 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Prebieha náborFáza 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Prebieha náborFáza 3
  • Clinical Neuroscience Solution, Orlando
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Prebieha náborFáza 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Prebieha náborFáza 3
  • Research Site, Ocoee · 10 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Prebieha náborFáza 3
  • West Orange Endocrinology, Ocoee · 10 míľ odtiaľ
Vek 45 až 99 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Prebieha náborFáza 3
  • Conquest Research, Winter Park · 5 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Prebieha náborFáza 2
  • Charter Research - Winter Park, Orlando
Vek 18 až 75 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Prebieha náborFáza 3
  • AURORA-1 Clinical Site, Winter Park · 5 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Prebieha náborFáza 3
  • AURORA-2 Clinical Site, Winter Park · 5 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Prebieha náborFáza 3
  • AdventHealth Orlando, Orlando
  • Orlando Health Heart Institute, Orlando
  • Guardian Research Organization LLC, Winter Park · 5 míľ odtiaľ
  • a 1 ďalších
Vek 18 až 99 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07037459

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

Prebieha nábor
  • University of Central Florida, Orlando
Vek 5 až 11 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
  • ACCOMPLISH-2 Research Site, Ocoee · 10 míľ odtiaľ
Vek 18 až 79 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Prebieha náborFáza 2
  • Charter Research - Winter Park, Orlando
Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Prebieha náborFáza 3
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Prebieha náborFáza 3
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Prebieha náborFáza 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 míľ odtiaľ
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Prebieha náborFáza 3
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
Vek 18 až 99 · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Prebieha náborFáza 3
  • Cardiovascular Institute of Orlando, Orlando
  • Guardian Research Org LLC, Winter Park · 5 míľ odtiaľ
  • K2 Medical Research, Maitland · 6 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Prebieha náborFáza 3
  • ACCOMPLISH-1 Research Site, Ocoee · 10 míľ odtiaľ
Vek 18 až 79 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT07654361

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

Prebieha náborVítaní zdravých dobrovoľníkov
  • AdventHealth Translational Research Institute, Orlando
Vek 18 až 45 · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT06602141

Štúdie Obézita v iných mestách

Iné štúdie v Orlando

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.